Data / Form D filings / Neuros Medical, Inc.
Neuros Medical, Inc.: Form D filings
Neuros Medical, Inc., a biotechnology company in Aliso Viejo, CA, filed 13 Form D notices with the SEC between 2009 and 2025. The latest, on August 6, 2025, reports $56 million sold of a $65 million offering to 28 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 26800 Aliso Viejo Pkwy, Suite 250, Aliso Viejo, CA, 92656
- Phone
- (440) 951-2565
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1474720
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | New notice | $64,999,994 | $55,999,997 | $8,999,997 | 28 | Jul 9, 2025 | sec.gov |
| Sep 25, 2023 | New notice | $20,000,431 | $20,000,000 | $431 | 41 | Jun 16, 2023 | sec.gov |
| Dec 19, 2022 | New notice | $10,000,000 | $8,229,699 | $1,770,301 | 40 | Nov 15, 2022 | sec.gov |
| Nov 3, 2020 | New notice | $42,777,148 | $36,981,418 | $5,795,730 | 24 | Oct 27, 2020 | sec.gov |
| Jun 10, 2020 | New notice | $5,500,000 | $2,200,000 | $3,300,000 | 5 | May 27, 2020 | sec.gov |
| Oct 22, 2019 | New notice | $9,235,791 | $2,385,759 | $6,850,032 | 4 | Oct 11, 2019 | sec.gov |
| Aug 16, 2017 | New notice | Indefinite | $0 | 55 | Aug 2, 2017 | sec.gov | |
| Aug 16, 2017 | New notice | $22,659,257 | $22,634,257 | $25,000 | 27 | Aug 3, 2017 | sec.gov |
| May 12, 2016 | New notice | $6,000,000 | $0 | $6,000,000 | 0 | Yet to occur | sec.gov |
| Feb 19, 2013 | New notice | $1,750,000 | $1,750,000 | 11 | Jan 22, 2013 | sec.gov | |
| Feb 11, 2013 | Amendment | $4,000,000 | $2,508,310 | $1,491,690 | 29 | Nov 22, 2011 | sec.gov |
| Jun 7, 2012 | New notice | $4,000,000 | $2,508,310 | $1,491,690 | 25 | Nov 22, 2011 | sec.gov |
| Oct 19, 2009 | New notice | $1,800,000 | $1,285,029 | $514,971 | 11 | Aug 20, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Veino | Executive Officer, Director | |
| Joyce Erony | Director | |
| William Harrington | Director | |
| Fouad Azzam | Director | |
| Zach Stassen | Executive Officer | |
| Casey Tansey | Director | |
| Marc-Andre Marcotte | Director | |
| Randy Ban | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 4, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Neuros Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.